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Measuring the eﬀects of fractionated radiation
therapy in a 3D prostate cancer model system
using SERS nanosensors
Victoria L. Camus,a Grant Stewart,b William H. Nailon,c Duncan B. McLarend and
Colin J. Campbell*a
Multicellular tumour spheroids (MTS) are three-dimensional cell
cultures that possess their own microenvironments and provide a
more meaningful model of tumour biology than monolayer cul-
tures. As a result, MTS are becoming increasingly used as tumor
models when measuring the eﬃciency of therapies. Monitoring
the viability of live MTS is complicated by their 3D nature and con-
ventional approaches such as ﬂuorescence often require ﬁxation
and sectioning. In this paper we detail the use of Surface Enhanced
Raman Spectroscopy (SERS) to measure the viability of MTS grown
from prostate cancer (PC3) cells. Our results show that we can
monitor loss of viability by measuring pH and redox potential in
MTS and furthermore we demonstrate that SERS can be used to
measure the eﬀects of fractionation of a dose of radiotherapy in a
way that has potential to inform treatment planning.
Introduction
Intracellular redox potential (IRP) is a measure of how oxidis-
ing or reducing the environment is within a cell. It is a func-
tion of numerous factors including redox couples, antioxidant
enzymes, reactive oxygen species (ROS), pH, oxygen concen-
tration and metabolic pathways. Disruption of the tightly regu-
lated redox status has been linked to the initiation and
progression of cancer, however, there is very limited knowledge
about the quantitative nature of the redox potential in cancer
tumour models.
Conventionally, cells are cultured as flat monolayers where
their only interactions are with the surface to which they
become adhered and to the surrounding media. Such an
environment is not a meaningful recreation of the complex
tumour microenvironment (TME) and as a result, drugs and
disease therapies that prove eﬀective in the monolayer cell
culture models often fail to carry this eﬃcacy forward into
in vivo trials. The solid TME is highly dynamic and consists of
heterogeneous sub-populations of cells, characterised by gradi-
ents of O2, pH and redox potential.
1 These can be modelled
in vitro by 3D cell cultures known as Multicellular Tumour
Spheroids (MTS). Unlike 2D cell monolayers, MTS more closely
resemble in vivo tumours due to their cellular communication
(cell–cell/cell–matrix), formation of extracellular matrices,
anchorage-independent growth, and oxygen gradients, and as
a result MTS have been widely used for studies of cancer
biology and radiobiological investigations.2
Radiation therapy (RT) is a therapeutic technique primarily
used to treat localised disease and destroy cancerous cells. The
ionising radiation generates ions and deposits energy in cells,
killing the cancerous tissue by damaging DNA and other cell
components including membranes, proteins and organelles
such as mitochondria. Mitochondria play an important role in
regulating apoptosis in response to ionising radiation with
radiation exposure resulting in loss of mitochondrial mem-
brane potential (ΔΨm) and permeabilisation (Fig. 1).3 As a
result, mitochondria release their contents, including cyto-
chrome C, into the cytosol.3,4 Cytochrome C release in turn
induces a series of biochemical reactions that result in caspase
activation and subsequent cell death.5,6 Coincident with mito-
chondrial membrane depolarisation and increased permeabili-
sation is an increase in intracellular pH, likely due to the
release of mitochondrial contents that are naturally more basic
pH than the cytosol.7
Despite its wide-spread use, only 33–66% of patients under-
going radiation treatment for prostate cancer are disease-free
five years after initial treatment.8 As part of the ongoing eﬀort
to improve the eﬃciency of radiotherapy, a method for measur-
ing and modelling potential tumour response to radiation treat-
ments may assist in optimising the outcome of therapy.
Raman spectroscopy (RS) has been used previously to study
radiation response within tumour cells and tissues including
lung (H460), breast (MCF7) and prostate (LNCaP) human cell
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lines.9,10 Raman spectra of biological materials provide spec-
tral fingerprints characteristic of the sample’s bimolecular
content hence RS can be used to detect cellular changes result-
ing from metabolic processes in response to radiation treat-
ment.9 RS is a label-free technique that enables the
identification of biomarkers in a non-destructive manner,
however, Raman is a weak eﬀect and spectra acquired have low
signal intensity. The Raman signal can be enhanced when a
reporter molecule is in close-proximity to a noble metal such
as gold or silver in a technique known as surface enhanced
Raman scattering (SERS). While SERS requires the delivery of
nanoparticles to the sample of interest (a potential limitation)
it can give targeted information such as pH and IRP in live
cells and with short acquisition times.
Our group has established a novel technique that allows
quantitative measurement of biomarkers, IRP and pH, in live
cell cultures using SERS nanosensor technology. These nano-
sensors consist of redox sensitive and pH sensitive probe mole-
cules attached to gold nanoshells (NS) whose SERS spectra
report on the redox potential and pH of the intracellular
environment. In this paper, we have investigated whether this
novel SERS method could be useful in monitoring the viability
of live 3D culture models, and furthermore we have used this
method to indicate the best fractionation regimes for maximis-
ing cell death in radiotherapy treatment.
Results and discussion
Nanosensor calibrations
We have previously reported that 2-chloro-3-[methyl(2-sulfanyl-
ethyl)amino]-1,4-dihydronapthalene-1,3-dione (MeNQ) can be
used as an intracellular redox sensor when functionalised to
gold NS (MeNQ·NS, Fig. 2A).11 Using transmission electron
microscopy (TEM) we investigated whether MeNQ·NS is readily
taken up by the PC3 human prostate cancer cell line. Fig. 2B
shows that MeNQ·NS can primarily be found in the cytoplasm
of PC3 cells. Spectroelectrochemistry of the probe showed a
change in intensity of several signals with varying redox poten-
tial.11 The most notable of these peaks were at 1111.47 cm−1
(aliphatic C–C stretching); 1311.47 cm−1 (symmetric ring
breathing); 1576.76 cm−1 (asymmetric ring breathing and C–N
stretching) and 1671.26 cm−1 (CvO stretching). The peak at
∼1576 cm−1 covers the greatest spectral area and its normal-
ised integral was therefore used to generate the calibration
shown in Fig. 2C. MeNQ can be used to measure redox poten-
tials in the range of −100 to −450 mV.
pMBA is a well-established SERS reporter used for the
measurement of pH.12,13 Similar to MeNQ, pMBA can be con-
jugated to gold NS (Fig. 2D) and transfected into PC3 cells
(Fig. 2E) where it can be found predominantly in the cyto-
plasm. pMBA·NS has a unique SERS fingerprint that changes
with pH. The most intense peak is found at ∼1590 cm−1, it is
attributed to aromatic ring breathing and most commonly
used as a reference peak because it is present at both low and
high pH.14 Two other characteristic peaks of pMBA·NS are at
∼1400 cm−1 and ∼1700 cm−1, corresponding to COO− and
CvO stretching, respectively. The 1700 cm−1 signal increases
with increasing pH, owing to increased deprotonation under
acidic conditions, whereas the intensity of the 1400 cm−1 peak
increases with decreasing pH.12 These peak heights and areas
can potentially be combined with the shift in the centre of the
peak located at 1590 cm−1 to generate an algorithm for signal
processing and analysis.14 An example using the ratio of
1590/1400 cm−1 peak heights is provided in Fig. 2D. pMBA·NS
covers a pH range of pH 6 to pH 8 making it suited to appli-
cation in the intracellular environment.
Nanosensor toxicity was assessed by an MTT assay where
proliferative capability and mitochondrial function is used as
an indicator of cell viability. NADPH-oxidoreductases cleave
the tetrazolium ring of yellow tetrazolium dye 3-(4,5 dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), yielding
purple formazan crystals which are insoluble in aqueous solu-
tions. The crystals are dissolved in acidified isopropanol and
the resulting purple solution spectrophotometrically measured
at 570 nm. Reduction takes place only when oxidoreductase
enzymes are active and therefore conversion can be directly
related to the number of viable cells. Nanosensor toxicity and
subsequent viability was assessed in PC3 monolayers (Fig. 3).
Using an unpaired one-tailed T-test with a threshold for sig-
nificance at P < 0.05, the % viability of cells transfected with
pMBA·NS was not significantly diﬀerent to the untreated
control, whereas MeNQ·NS resulted in a small statistically sig-
nificant change. The negligible toxicity of MeNQ·NS can,
however, be optimised by tuning concentrations.
Measuring changes in IRP and pH by chemical treatment of MTS
Redox dysregulation is a hallmark of the aggressive pheno-
type of prostate cancer, facilitating the development and
Fig. 1 Schematic showing the link between ionising radiation, mito-
chondria and cell death. Ionising radiation results in depolarisation and
permeabilisation of the mitochondrial membrane, followed by release of
the alkaline contents and cytochrome C, an inducer of the caspase
pathway and subsequent apoptosis.
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progression of tumours but also aﬀecting response to
therapy.15 Radiation therapy induces oxidative changes in cells
by the generation of free radicals. An understanding of the
relationships between redox homeostasis and radiation
therapy in prostate disease, however, remains unclear.
Using our novel SERS technique, the behaviour of
MeNQ·NS and pMBA·NS in MTS was initially measured to
demonstrate the ability to monitor changes in IRP and pH in
live cultures. Oxidative and reductive stress was therefore
chemically induced using AAPH and CoCl2, respectively. As
shown in Fig. 4, treatment of MTS with AAPH, a membrane
permeable free-radical generator, resulted in a more oxidising
redox potential (−248 mV) than the untreated MTS (−264 mV).
In contrast, treatment with the hypoxia mimetic CoCl2 gener-
ated a more reducing IRP (−274 mV). Both treatments resulted
in redox potentials that were significantly diﬀerent to the
untreated condition i.e. P < 0.05. In terms of pH, only AAPH
treatment resulted in a significant change (P < 0.05) with the
MTS measuring an average of pH 6.97 compared to the
untreated MTS (pH 7.20). CoCl2 treated MTS measured at pH
7.19 (P > 0.05). These data demonstrate that we can make
measurements in 3D culture that correlate with oxidative or
reductive stress and that it is important to measure both pH
and redox potential in order to understand how the MTS
change.
Monitoring the eﬀects of fractionation regimes on MTS IRP
and pH
Within the clinic it is common practice to deliver radiation
therapy to patients in a series of small doses or ‘fractions’ with
the primary advantage being that it allows the repair of sub-
lethal radiation damage to normal tissue. Additional benefits
Fig. 2 (A) Structure and equilibrium between oxidised and reduced forms of MeNQ·NS (yellow sphere represents gold NS, not to scale). (B) TEM
image of MeNQ·NS in the cytoplasm of a PC3 cell. (C) Calibration curve for MeNQ·NS (D) Equilibrium between protonated and deprotonated forms
of pMBA·NS. (E) TEM image of pMBA·NS in the cytoplasm of a PC3 cell. (F) Peak height calibration curve for pMBA·NS.
Fig. 3 MTT assay assessing viability of PC3 cell monolayers. Error bars
represent the standard deviation of three repeats. Untreated (control) =
100% viability. MeNQ = 87.5 ± 6.09%. pMBA = 97.9 ± 6.05%.
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over issuing a single large dose include that tumour cells in a
radioresistant phase of the cell cycle during one treatment are
given an opportunity to cycle into a sensitive phase of the cycle
before the next fraction is given.16 Similarly, the interval pro-
vides hypoxic (and therefore radioresistant) cancer cells a
chance to re-oxygenate between fractions.17
In order to investigate the impact of radiation fractionation
schedules on MTS viability, a single dose of 12 Gy, and 12 Gy
issued in multi-fractions (3 × 4 Gy, 2 × 6 Gy and 1 × 12 Gy)
were delivered using a Faxitron X-ray cabinet. Each set of MTS
received their final radiation dose on the same day and SERS
spectra of MeNQ·NS and pMBA·NS recorded after 24 h
incubation. Fig. 5 illustrates the IRP and pH measurement
acquired from MTS treated with the aforementioned fraction-
ation schedules from three independently replicated experi-
ments. The resting pH’s for each data set were comparable
measuring at pH 6.96, 7.01 and 7.03. Treatment with 3 × 4 Gy
did not result in a significant change to the untreated pH
(P < 0.05) in any data set, whilst 1 × 12 Gy caused a significant
decrease in pH (P > 0.05) during the second and third repeats.
In contrast, 2 × 6 Gy resulted in an increase in pH (P > 0.05)
across all data sets. Measured redox potentials were corrected
for pH prior to ANOVA analysis. Untreated PC3 MTS had
resting IRPs within the range of −292 to −297 mV. Treatment
with 3 × 4 Gy and 1 × 12 Gy resulted in a general shift towards
more oxidative redox potentials in the MTS whilst 2 × 6 Gy
Fig. 4 Chemical induction of oxidative and reductive stress in PC3 MTS using AAPH and CoCl2. (A) Example baseline-subtracted spectra of
MeNQ·NS aquired from unreated and chemically treated PC3 MTS. (B) IRP shifted towards a more positive potential after AAPH treatment and
towards a more negative potential with CoCl2. (C) AAPH resulted in a more acidic pH whilst CoCl2 caused no signiﬁcant change in pH. Measure-
ments with a P-value <0.05 are indicated by *.
Fig. 5 pH and pH corrected redox potentials for untreated MTS and those treated with 3 × 4 Gy, 2 × 6 Gy and 1 × 12 Gy of X-ray radiation. Measure-
ments shown represent 3 independent data sets consisting of 10 measurements for each treatment. Treatments that are signiﬁcantly diﬀerent to
untreated samples (with a P-value <0.05) are indicated by *.
Analyst Communication
This journal is © The Royal Society of Chemistry 2016 Analyst, 2016, 141, 5056–5061 | 5059
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
6 
Ju
ne
 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
1/
09
/2
01
6 
15
:2
8:
28
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
showed the greatest change in IRP relative to the untreated
MTS, generating a significantly more reducing potential in all
data sets.
Fluorescent images of MTS following single and fractio-
nated treatment were also recorded so as to correlate changes
in IRP and pH with MTS morphology. Untreated MTS naturally
possess a rounded exterior (Fig. 6). MTS treated with 3 × 4 Gy
and 1 × 12 Gy of ionising radiation showed no obvious change
in shape and only small changes in granularity, however, those
treated with 2 × 6 Gy demonstrated erosion of the outer layer
of cells and fragmentation suggesting loss of structural integ-
rity and viability. The deteriorating morphology of MTS treated
with 2 × 6 Gy can be linked to the measured increase in intra-
cellular pH. Alkalosis is an indicator of apoptosis resulting
from depolarisation and permeabilisation of the mitochon-
drial membrane and subsequent release of the alkaline con-
tents into the cytosol. The large alkaline pH change for the
2 × 6 Gy treatment contributes to the large change in redox
potential and is clearly a major contributory factor.
Methods
Nanosensor functionalisation
Approximately 1 mg of the redox reporter MeNQ was weighed
out and dissolved in DMSO (1 mL). 8–10 µL of the DMSO solu-
tion was then diluted in EtOH to give a 10 µM solution of the
probe molecule. The solution was then gravity filtrated once
through cotton wool in a glass pipette into a new bijou, and
then the filtrate passed through a Millex GP PES 33 mm
0.22 µM filter (Millipore): 50 µL of the resulting solution was
added to 450 µL of gold nanoshells (125 nm silica core, 25 nm
gold shell, Nanospectra Biosciences Ltd) in an autoclaved
eppendorf and stored upright in the fridge overnight. A similar
procedure was used for pMBA except the NS were functionalised
with 100 µM solution of the compound in 10% EtOH.
Nanosensor calibration
MeNQ·NS. SERS spectroelectrochemistry was carried out as
described by Thomson et al.11 Spectral analysis was performed
using MATLAB R2016a to subtract a 16 pt baseline. The peak
integral was then derived by the extraction of two peak areas:
1500 cm−1 to 1612 cm−1 (peak) and 397 cm−1 and 1750 cm−1
(total) before plotting (total area − peak area)/(total area) vs.
redox potential.
pMBA·NS. pMBA spectra were processed with customised
scripts in Matlab provided by Kate Fisher.14 Briefly, a back-
ground was first subtracted and a Lorentzian peak shape on a
linear baseline was then fit individually to the three peaks at
∼1400, ∼1590 and ∼1700 cm−1. Seven parameters were
extracted: the centre of the peak at ∼1590 cm−1, and the ratios
of the heights and areas of the peaks 1590/1400, 1590/1700
and 1400/1700 cm−1. The pH for each parameter was extracted
from the relevant calibration curve and the associated error
determined from the error in both the Lorentzian fit and the
calibration curve. A weighted mean of the seven parameters
using inverse weighting was performed to minimise the eﬀect
of parameters with a large error. An overall pH value was
returned for those spectra where at least 4 out of the 7 para-
meters were within the pH range of 6–8 (the working range as
determined from the calibration curves), otherwise the spec-
trum was marked as acidic or basic, as appropriate.
Cell culture
PC3 prostate cancer cells were cultured in RPMI 1640 media
supplemented with penicillin/streptomycin (10 000 units per ml)
and 10% heat-inactivated Foetal Calf Serum (FCS). Cells were
incubated at 37 °C and 5% CO2 in a humidified incubator.
MTS formation. A hanging drop technique was used for
spheroid growth. Cells were first seeded in 25 mL flasks. After
24 h, media was removed, the cells washed with PBS and serum-
free medium (5 mL) added. For homogenous distribution of NS
throughout the MTS, cells were incubated overnight with
MeNQ·NS and pMBA·NS (500 µL) before aliqouting the cell sus-
pension into hanging-drops: 20 µl drops of cell suspension were
pipetted onto the lid of a petri dish and 10 ml of media was
added to the base. The lid containing hanging drops was placed
on the petri dish and MTS grown over a period of 6 days.
Intracellular SERS measurements
SERS measurements were recorded using an Ocean Optics
QE65 Pro spectrometer (Ocean Optics) with Ocean Optics RPB
fibre optic probe. The Ocean Optics was equipped with a
785 nm laser with 350 mW power. Spectra were acquired over a
10–20 s acquisition period using Spectra Suite software and
processed using Origin 9 and MATLAB software. MTS were
pipetted onto glass slides sputtered with Cr (3 nm) and Au
(150 nm) in a Denton Vacuum Desk III prior to measurements.
Chemical treatment of MTS
15 µL of media was removed from each hanging-drop and
replaced with AAPH (1 mM) or CoCl2 (500 µM) in media for
Fig. 6 Fluorescent images of PC3 MTS untreated (i) and treated with
3 × 4 Gy (ii), 2 × 6 Gy (iii) and 1 × 12 Gy (iv). Scale bar = 500 µm.
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1 h and 4 h, respectively. SERS spectra of MeNQ·NS and
pMBA·NS were then acquired.
Radiation treatment of MTS
MTS were irradiated in a Faxitron Cabinet X-ray System
(Faxitron X-ray Corporation) operated at 180 kV. The dose
rate was 1 Gy per min and this protocol was used for all
experiments.
Single and multi-fractionated radiation treatment. MTS were
exposed to 12 Gy of radiation in multi-fractionated doses of:
1 × 2 Gy for 6 days, 1 × 4 Gy for 3 days, and 1 × 6 Gy for 2 days.
For the single dose a total of 12 Gy was administered (12 Gy × 1)
during the last day of the multi-fractionated radiation treat-
ments. For both single and fractionated radiation-treated MTS,
SER spectra of pMBA·NS and MeNQ·NS were recorded 24 h
after the final dose.
Conclusions
In this paper we have demonstrated the use of SERS and
nanosensor technology to monitor the in vitro response of
MTS to ionising radiation. The pH probe pMBA·NS and redox
sensor MeNQ·NS were calibrated and shown to be responsive
in the ranges of pH 6–8 and −100 to −450 mV, respectively.
Their ability to measure changes in pH and IRP in live MTS
cultures was also demonstrated by chemical induction of oxi-
dative and reductive stress using AAPH and CoCl2. Establish-
ment of this model system subsequently enabled the
measurement of pH and IRP in MTS following X-ray exposure.
A total radiation dose of 12 Gy was issued as a single dose or
in multi-fractions (3 × 4 Gy or 2 × 6 Gy). Treatment of MTS
with 2 × 6 Gy resulted in a significantly more basic pH and
reducing IRP compared to the untreated MTS, as well as clear
disintegration of MTS morphology thereby correlating with
the link between alkalosis and cell death. In comparison,
MTS treated with 3 × 4 Gy and 1 × 12 Gy showed no large
changes in either pH or IRP as well as no obvious changes in
morphology. Of the three regimes issued, the 2 × 6 Gy multi-
fraction was therefore the optimum radiation treatment for
inducing cell death.
Using this technique the viability of live MTS cultures can
be quantitatively assessed and fractionation regimes optimised
for maximising cell death. This novel method for measuring
the metabolic markers IRP and pH is therefore a potential new
platform for in vitro preclinical characterisation of tumour
models, enabling clinicians to design and tailor therapy
better.
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